Abbott Laboratories (ABT) Cash & Equivalents Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 32.23% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.31% |
| Mar 31, 2026 | -9.44% |
| Dec 31, 2025 | -4.82% |
| Sep 30, 2025 | -7.84% |
| Jun 30, 2025 | -8.04% |
| Mar 31, 2025 | -5.23% |
| Dec 31, 2024 | -8.06% |
| Sep 30, 2024 | -6.69% |
| Jun 30, 2024 | -6.90% |
| Mar 31, 2024 | -7.94% |
| Dec 31, 2023 | 0.28% |
| Sep 30, 2023 | 14.41% |
| Jun 30, 2023 | 18.05% |
| Mar 31, 2023 | 39.47% |
| Dec 31, 2022 | 36.80% |
| Sep 30, 2022 | 32.86% |
| Jun 30, 2022 | 41.76% |
| Mar 31, 2022 | 36.44% |
| Dec 31, 2021 | 25.28% |
| Sep 30, 2021 | 8.07% |